Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Debt Ratio (2016 - 2022)

Historic Debt Ratio for Lexaria Bioscience (LEXX) over the last 12 years, with Q2 2022 value amounting to 0.0.

  • Lexaria Bioscience's Debt Ratio rose 2156.08% to 0.0 in Q2 2022 from the same period last year, while for May 2022 it was 0.0, marking a year-over-year increase of 2156.08%. This contributed to the annual value of 0.0 for FY2021, which is 9810.93% down from last year.
  • As of Q2 2022, Lexaria Bioscience's Debt Ratio stood at 0.0, which was up 2156.08% from 0.0 recorded in Q1 2022.
  • In the past 5 years, Lexaria Bioscience's Debt Ratio registered a high of 0.05 during Q4 2020, and its lowest value of 0.0 during Q3 2021.
  • Over the past 5 years, Lexaria Bioscience's median Debt Ratio value was 0.0 (recorded in 2018), while the average stood at 0.01.
  • As far as peak fluctuations go, Lexaria Bioscience's Debt Ratio plummeted by 9939.45% in 2018, and later surged by 200909.1% in 2021.
  • Quarter analysis of 5 years shows Lexaria Bioscience's Debt Ratio stood at 0.01 in 2018, then surged by 121.72% to 0.01 in 2019, then soared by 300.74% to 0.05 in 2020, then tumbled by 98.77% to 0.0 in 2021, then surged by 30.0% to 0.0 in 2022.
  • Its last three reported values are 0.0 in Q2 2022, 0.0 for Q1 2022, and 0.0 during Q4 2021.